A Phase II Study of a Daily x 4 Schedule of Vinorelbine Plus Cisplatin for Advanced Non-small Cell Lung Cancer.

Autor: Han, Ji-Youn, Kim, Ki Won, Kim, Jung Ah, Kang, Jin Hyung, Jin, Jong-Youl, Hong, Young Seon, Park, Suk Young, Song, Jung-Sup, Park, Jong Won, Kim, Hoon-Kyo, Lee, Kyung Shik, Choi, Byung Gil
Zdroj: Japanese Journal of Clinical Oncology; Oct2000, Vol. 30 Issue 10, 4 Charts, 1 Graph
Abstrakt: Explores the possibility of increasing the dose of advanced non-small cell lung cancer drug, vinorelbine on a four times daily schedule to determine whether dose intensity affects response to the drug. Overall response rate; Toxicity of myelosuppression; Comparable therapeutic activity of the regimen with advanced lung cancers.
Databáze: Complementary Index